Work

Abstract 5616: Crystal structure of drug-resistant ROS1 G2032R in complex with zidesamtinib, a clinical-stage ROS1 inhibitor with best-in-class potential

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5616

Authors: Joseph M. Magrino, Anupong Tangpeerachaikul, Henry Pelish, Scot Mente

Institution: Nuvalent, Inc. (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409631067

Cites:

Cited by:

Related to: 10